Skip to main content
SR biotek Inc. logo

SR biotek Inc. — Investor Relations & Filings

Ticker · 270210 ISIN · KR7270210008 KO Manufacturing
Open in API
Filings indexed 190 across all filing types
Latest filing 2026-05-13 Regulatory Filings
Country KR South Korea
Listing KO 270210

About SR biotek Inc.

http://srbiotek.com/

SR biotek Inc. is a biotechnology and cosmeceutical company specializing in the research, development, and manufacturing of innovative skincare products. The company offers comprehensive turnkey OEM/ODM solutions to its partners, covering product development, quality control, and manufacturing. A core strength lies in the development of novel ingredients, highlighted by its proprietary bio-material, RAPHITOX, which utilizes a micro-needle shaped structure. In addition to its manufacturing services, SR biotek also develops its own branded skincare lines.

Recent filings

Filing Released Lang Actions
기업설명회(IR)개최결과
Regulatory Filings Classification · 25% confidence The document is a Korean regulatory announcement summarizing the holding of an Investor Relations (IR) briefing (“기업설명회(IR) 개최 결과”). It lists date, venue, attendees, agenda, and posting details on the Korean Exchange’s disclosure system. It does not contain actual financial statements, a slide deck, or detailed investor presentation content; nor is it an interim or annual report. It is a miscellaneous regulatory filing announcing the IR meeting results, fitting the fallback category “Regulatory Filings” (RNS).
2026-05-13 Korean
기업설명회(IR)개최
Investor Presentation Classification · 90% confidence The document is a formal announcement of an upcoming investor relations event (“기업설명회(IR) 개최”) including date, time, venue, participants, agenda, and registration details. It is not a financial report, earnings release, or regulatory form, but rather an invitation/presentation for investors. This aligns with the “Investor Presentation” category.
2026-04-24 Korean
[기재정정]전환주식의전환청구권행사
Share Issue/Capital Change Classification · 85% confidence The document is a corporate disclosure concerning the exercise of conversion rights on redeemable convertible preferred shares and a correction (“정정신고”) to a previously filed notice. It details the conversion date, number of shares converted, impact on total issued shares, and changes to capital. This is not an earnings release, management change, or full financial report but a specific notice of share capital changes due to a conversion event. Under FinancialReports taxonomy, this falls squarely under Share Issue/Capital Change (Code: SHA).
2026-04-16 Korean
전환주식의전환청구권행사
Share Issue/Capital Change Classification · 88% confidence The document is a corporate disclosure detailing the exercise of conversion rights on the company’s redeemable convertible preferred shares. It provides the number of shares converted, resulting changes in share capital and outstanding shares. This is not a full financial report but an announcement of new share issuance and capital change. According to the filing definitions, this falls under “Share Issue/Capital Change” (Code: SHA).
2026-04-01 Korean
주식매수선택권부여에관한신고
Share Issue/Capital Change Classification · 88% confidence The document is a Korean stock exchange filing notifying the Financial Services Commission/KRX of the grant of stock acquisition rights (주식매수선택권) to directors and employees, detailing issuance date, conditions, quantities, and fair value. This is an announcement of a capital change via a new stock option issuance, matching the 'Share Issue/Capital Change' category.
2026-03-24 Korean
주식매수선택권부여에관한신고
Share Issue/Capital Change Classification · 82% confidence The document is a formal regulatory notice (in Korean) filed with the Financial Services Commission/Korea Exchange concerning the grant of stock options (“주식매수선택권 부여에 관한 신고”) and detailing the number of shares, exercise price, vesting period, participants, and legal basis. This is not an earnings release, annual report, director’s trade, nor a general regulatory fallback. It specifically relates to a planned share issuance mechanism (options) and is best classified as a Share Issue/Capital Change announcement. Thus, SHA (Share Issue/Capital Change) is the appropriate code.
2026-03-24 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.